HealthEquity (HQY) vs Xometry (XMTR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Xometry (XMTR) has outperformed HealthEquity (HQY) over the past year, gaining 114.5% versus a loss of 0.2%. Over five years, XMTR leads with a +85.5% price change compared with +46.7% for HQY. HealthEquity is the larger company by market cap ($7.66 billion vs $6.37 billion), about 1.2 times the size, while Xometry is growing revenue faster (+25.9% vs +9.5%).
On valuation, HealthEquity trades at a lower forward P/E (16.8x vs 86.5x for Xometry). HealthEquity converts more of its revenue into profit, with a net margin of 16.4% versus -9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HQY | XMTR |
|---|---|---|
| Share price | $92.61 | $111.07 |
| Market cap | $7.66B | $6.37B |
| 1-day change | -0.47% | +4.31% |
| YTD return | +1.09% | +86.77% |
| 1-year return | -0.18% | +114.55% |
| 5-year return | +46.65% | +85.49% |
| P/E ratio (TTM) | 33.43 | — |
| Forward P/E | 16.84 | 86.55 |
| EPS (TTM) | $2.77 | $-0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.31B | $686.63M |
| Revenue growth (YoY) | +9.47% | +25.87% |
| Net income (latest FY) | $215.20M | $-61.75M |
| Gross margin | 69.52% | 39.14% |
| Operating margin | 24.55% | -6.63% |
| Net margin | 16.38% | -8.99% |
| 52-week high | $107.62 | $112.94 |
| 52-week low | $72.76 | $35.86 |
| Distance from 52-week high | -13.95% | -1.66% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +28.85% | +0.92% |
| Average volume | 844.82K | 757.19K |
| Shares outstanding | 82.72M | 55.85M |
| Employees | 2,814 | 1,174 |
| Sector | Consumer Discretionary | Industrials |
| Industry | Business Services | Industrial Distribution |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XMTR has outperformed HQY by 114.7 percentage points over the past year.
- HealthEquity is more profitable, keeping 16.4 cents of every revenue dollar as net income versus -9.0 cents for Xometry.
- Xometry grew revenue faster in its latest fiscal year (+25.87% vs +9.47%).
- The two companies sit in different sectors: HealthEquity in Consumer Discretionary and Xometry in Industrials.
About HealthEquity
HQY stock →HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States.
Consumer Discretionary · Business Services · 2,814 employees
About Xometry
XMTR stock →Xometry, Inc. operates an artificial intelligence (AI) powered online manufacturing marketplace in the United States and internationally.
Industrials · Industrial Distribution · 1,174 employees
HQY vs XMTR FAQ
Which is bigger, HealthEquity or Xometry?
HealthEquity (HQY) is larger, with a market capitalization of $7.66B compared with $6.37B for Xometry (XMTR).
Which stock has performed better over the past year, HQY or XMTR?
XMTR returned +114.55% over the past 12 months, compared with -0.18% for HQY (price return, excluding dividends). Past performance does not predict future results.
Are HealthEquity and Xometry in the same industry?
No. HealthEquity is in the Consumer Discretionary sector, while Xometry is in Industrials.